Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SELLAS Life Sciences (SLS) Other Non-Current Liabilities (2019 - 2022)

SELLAS Life Sciences (SLS) has disclosed Other Non-Current Liabilities for 7 consecutive years, with $170000.0 as the latest value for Q3 2022.

  • Quarterly Other Non-Current Liabilities fell 96.62% to $170000.0 in Q3 2022 from the year-ago period, while the trailing twelve-month figure was $170000.0 through Sep 2022, down 96.62% year-over-year, with the annual reading at $296000.0 for FY2021, 93.61% down from the prior year.
  • Other Non-Current Liabilities for Q3 2022 was $170000.0 at SELLAS Life Sciences, down from $181000.0 in the prior quarter.
  • The five-year high for Other Non-Current Liabilities was $5.2 million in Q2 2020, with the low at $170000.0 in Q3 2022.
  • Average Other Non-Current Liabilities over 4 years is $3.7 million, with a median of $4.8 million recorded in 2019.
  • The sharpest move saw Other Non-Current Liabilities rose 8.01% in 2020, then crashed 96.62% in 2022.
  • Over 4 years, Other Non-Current Liabilities stood at $4.9 million in 2019, then dropped by 5.68% to $4.6 million in 2020, then tumbled by 93.61% to $296000.0 in 2021, then tumbled by 42.57% to $170000.0 in 2022.
  • According to Business Quant data, Other Non-Current Liabilities over the past three periods came in at $170000.0, $181000.0, and $296000.0 for Q3 2022, Q2 2022, and Q1 2022 respectively.